Wound Care News: Breaking Wound Care News, Comments and Articles. - Page: 5

A DNA-unraveling enzyme in neutrophils is essential for deep vein thrombosis

BOSTON, May 6, 2013 /PRNewswire-USNewswire/ -- It takes more than platelets, thrombin and fibrin to build a deep vein thrombosis (DVT). Increasingly, researchers are recognizing that neutrophils—cells better known for their role in immune defense—play an active role in DVT formation by releasing platelet-catching nets made of chromatin, a tightly-wound mix of DNA and associated protein...

Onset Dermatologics Launches Patented Aurstat® Anti-Itch Hydrogel 225mL

Onset Dermatologics, a PreCision Dermatology Company and a leader in developing and commercializing novel, prescription products for improving skin health, today announced the availability of Aurstat® Anti-Itch Hydrogel. Aurstat® is a treatment for itch, including itch related to atopic dermatitis. Atopic dermatitis is also called eczema. Aurstat® conta...

Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Disposable Wound Protection Retractors

The Premier healthcare alliance today announced new agreements for disposable wound protection retractors have been awarded to Applied Medical Distribution Corporation of Rancho Santa Margarita, Calif.; and CooperSurgical Inc. of Trumbull, Conn. Effective May 1, 2013, the agreements are available to acute care and continuum of care members...

Organogenesis Presents Data at SAWC 2013 Demonstrating Apligraf® Speed and Incidence of Wound Closure in Real-world Analysis of Venous Leg Ulcer Patients

CANTON, Mass., May 6, 2013 /PRNewswire/ -- Organogenesis Inc., a commercial leader in the field of regenerative medicine, announced today key findings demonstrating the speed and incidence of wound closure for venous leg ulcer (VLU) patients who were treated with Apligraf®. The oral presentation of the abstract, titled "A Retrospective Analysis of a Bilayered Living Cellular Construct an...

Neogen launches comprehensive cattle genomic test

LANSING, Mich., May 6, 2013 /PRNewswire/ -- Neogen Corporation (Nasdaq: NEOG) announced today the development of a new genomic test that offers the beef cattle industry an unprecedented level of information on the genetic potential of individual animals. Neogen's new GeneSeek® Genomic Profiler™ (GGP-HD) contributes comprehensive data included in Angus genomic-enhanced expected pr...

Cytomedix to Host First Quarter 2013 Financial Results Conference Call on Friday, May 10, 2013

GAITHERSBURG, MD -- (Marketwired) -- 05/06/13 -- Cytomedix, Inc. (OTCQX: CMXI), a regenerative therapies company commercializing and developing innovative platelet and adult stem cell technologies, announced today that the Company will release financial results for the three-month period ended March 31, 2013, after the close of the market on Thursday, May 9, 2013. Martin Rosendale, Chief Executi...

Synedgen Announces Effective Treatment Against Bacterial Biofilms in Minor Animal Species

Claremont CA (PRWEB) May 05, 2013 Removing embedded bacteria from biofilms in wounds remains a challenge to doctors and caregivers. Likewise, veterinarians face similar challenges treating their zoo patients. Synedgen will report compelling data o...

ArthroCare Announces Date for First Quarter 2013 Financial Results Press Release and Conference Call

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to announce its first quarter 2013 results on Tuesday, May 7, 2013. ArthroCare plans to issue a press release for the first quarter 2013 after the market closes on Tuesday, May 7, 2013, and will host a conference call the following...

Misonix, Inc. To Report Financial Results For The Third Quarter Fiscal 2013 On Thursday, May 9, 2013

FARMINGDALE, N.Y., May 3, 2013 /PRNewswire/ -- Misonix, Inc. (Nasdaq: MSON), a surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery and other surgical applications, announced today that it will report financial results for the third qu...

Genetic Factors May Influence Gastric Bypass Surgery Success

redOrbit Staff & Wire Reports - Your Universe Online A DNA sequence variation can help predict the amount of weight loss that a person will experience following gastric bypass surgery, researchers from Massachusetts General Hospital (MGH), Merck Research Laboratories, and the National Institute of Diabetes and Digestive and Kidney Diseases claim in a new study. The study, which was published...

Kerecis Completes Successful Immunology Study

DENVER, CO -- (Marketwired) -- 05/03/13 -- Symposium on Advanced Wound Care -- Kerecis today announced that its recent clinical trial found no allergenic reactions to its fish-skin-composed MariGen Omega3 technology. In the trial, 40 patients were tested for allergic reactions after having their skin challenged with MariGen Omega3. Kerecis made the announcement at the Symposium on Advanced Wound...

New Invia® Motion™ Offers Increased Patient Mobility and Freedom

MCHENRY, Ill., May 2, 2013 /PRNewswire/ -- Medela today announces the availability of Invia® Motion™ Negative Pressure Wound Therapy (NPWT) System for treating chronic and acute wounds. A personal device for every patient, Invia Motion offers a full choice of therapy options, and promotes improved patient mobility and freedom. Invia Motion's small and lightweight design helps facilitat...

BioElectronics to Ease pain in Iraq

FREDERICK, Md., May 2, 2013 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of unique, safe, inexpensive, patented, pain products announced today that it has established distribution in Iraq with Mazaya Scientific Bureau for its ActiPatch® musculoskeletal therapy, Allay™ menstrual pain, and RecoveryRx™ post-operative and chronic wound products. Mazaya...

Bausch + Lomb Introduces INCISE® Microincision Intraocular Lens in Europe

ALISO VIEJO, Calif. and KINGSTON, England, May 2, 2013 /PRNewswire/ -- Bausch + Lomb, the global eye health company, announces the launch of its new INCISE® microincision intraocular lens (IOL). This enhanced acrylic IOL, in combination with the capabilities of the Stellaris® Vision Enhancement System, allows surgeons to perform microincision cataract surgery less than 2mm, del...

Alliqua to Present Results Demonstrating Antimicrobial Properties of SilverSeal® at SAWC SPRING 2013

NEW YORK, May 2, 2013 /PRNewswire/ -- Alliqua, Inc. (OTCQB:ALQA) ("Alliqua" or the "Company") today announced it will present the results of two in vitro studies investigating the antimicrobial properties of the Company's SilverSeal® hydrogel dressing. Data from these studies indicate that SilverSeal may be capable of rapid and sustained efficacy in managing the occurrence of wound conta...

Cytomedix AutoloGel(TM) Registry to Be Featured at the Symposium on Advanced Wound Care (SAWC-SPRING) on May 5, 2013

GAITHERSBURG, MD -- (Marketwired) -- 05/02/13 -- Cytomedix, Inc. (OTCQX: CMXI), a regenerative therapies company commercializing and developing innovative platelet and adult stem cell technologies, announced today that AutoloGel™ will be featured in oral and poster presentations at the Symposium on Advanced Wound Care (SAWC), that is being held in Denver, Colorado on May 1- 5, 2013. Dr. Carolin...

Coordinating Hospital Meal Delivery with Insulin Dosing Equals Better Outcomes for Diabetes Patients

In some instances, a simple solution may be the best solution to a vexing problem. Improving communication between hospital nursing staff and food service employees results in significantly better blood sugar control for hospitalized patients with diabetes, according to research presented at the American Association of Clinical Endocrinologists (AACE) 22nd...

A Drug-By-Drug Analysis Of Merck’s Big Earnings Miss

Merck’s first-quarter earnings are a big disappointment. Technically, earnings per share of $0.85 beat analyst forecasts by six cents due to one-time tax benefit. Meanwhile overall sales of $10.7 billion are 4% — a full $500 million ̵...

Theragenics Launches Antibacterial Suture for the Veterinary Market

Innovative Addition to our CP Medical Veterinary Products Theragenics Corporation® (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, today announced that CP Medical (a wholly-owned subsidiary of Theragenics) launched its “PLUS” line of antibacterial sutures for use in the veterinary market....

Scientists Decode "Molecular Chatter" That Makes Cancer Cells Spread

For the first time, scientists in the US have decoded the "molecular chatter" that makes cancer cells more aggressive and more likely to travel and set up tumors in other parts of the body (metastasize). The discovery came about as a result of brin...

ACell Receives SMARTCAP award from NASA-funded Space Research Institute

COLUMBIA, Md., May 1, 2013 /PRNewswire/ -- ACell, Inc., a leading developer of next-generation regenerative medicine products, announced today that it has received the Space Medicine and Related Technologies Commercialization Assistance Program (SMARTCAP) award, given by National Space Biomedical Research Institute's (NSBRI) Industry forum. The award will support ACell in the development of i...

MiMedx Announces Record First Quarter 2013 Results

KENNESAW, Ga., May 1, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NasdaqCM: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the quarter ended March 31, 2013. Highlights of First Quarter 2013 Results include: Revenue exceeded forecast for fifth consecutive...

New evidence to be presented in Systagenix symposium at EWMA 2013 confirms EPA to be highly predictive of skin graft failure

The results of a recently completed study confirming for the first time the relationship between elevated protease activity (EPA) and skin graft failure will be presented at the European Wound Management Association (

Breakthrough Microcurrent Technology Product Procellera® Featured in Eight Scientific and Clinical Abstracts at SAWC May 2 - 5

CHANDLER, Ariz., May 1, 2013 /PRNewswire/ -- Vomaris Innovations, Inc., a regenerative medical device company specializing in microcurrent field generating technologies for the wound care market, announced that eight scientific and clinical abstracts on its flagship product Procellera® will be presented at the 26th Annual Symposium on Advanced Wound Care (SAWC) May 2 - 5, 2013 at the Denver C...

Celsus Therapeutics Strengthens Board of Directors With Addition of Dermatology Industry Veteran Robert F. Doman

NEW YORK, NY and LONDON -- (Marketwired) -- 05/01/13 -- Celsus Therapeutics (OTCQB: MRRBY), an emerging growth, development-stage biotech company, announced the addition of industry veteran Robert F. Doman to the Company's Board of Directors. "We are pleased that Bob has joined our board of directors," said Gur Roshwalb, Chief Executive Officer of Celsus Therapeutics. "He brings more than 30 yea...